- 101. Kaschin-Beck disease involving lower leg
- [ ] (UMLS (ICD9CM) C0157974) =Disease or Syndrome
| - 151. keratitis
- [inflammation of the cornea. ( CSP )] (UMLS (CSP) C0022568) =Disease or Syndrome ;
=cornea;
=BETZURINGOKO ULTZERA(INKL.HERPESA);
keratoconjunctivitis;
Acanthamoeba keratitis;
BETZURINGOKO ULTZERA(INKL.HERPESA);
Keratitis, Herpetic;
keratoconjunctivitis;
|
- 102. Kaschin-Beck disease involving multiple sites
- [ ] (UMLS (ICD9CM) C0157977) =Disease or Syndrome
| - 152. KERATITIS IN EXANTHEMA
- [ ] (UMLS (ICD9CM) C0155086) =Disease or Syndrome
|
- 103. Kaschin-Beck disease involving pelvic region and thigh
- [ ] (UMLS (ICD9CM) C0409970) =Disease or Syndrome
| - 153. KERATITIS NEC
- [ ] (UMLS (ICD9CM) C0348526) =Disease or Syndrome
|
- 104. Kaschin-Beck disease involving shoulder region
- [ ] (UMLS (ICD9CM) C0157969) =Disease or Syndrome
| - 154. Keratoacanthoma
- [benign papular lesion with a superficial crater filled with a keratin plug, usually on the face. ( CSP )] (UMLS (NCI) C0022572) =Neoplastic Process ;
=Cutaneous Disorder;
|
- 105. Kaschin-Beck disease involving upper arm
- [ ] (UMLS (ICD9CM) C0157970) =Disease or Syndrome
| - 155. keratocentesis
- [ ] (UMLS (CSP) C0197430) =Therapeutic or Preventive Procedure ;
|
- 106. Kashaya
- (UMLS (HL7) C1555634) Southwestern Pomo;
=Language =Pomoan;
| - 156. KERATOCONJUNCTIVIT SICCA
- [ ] (UMLS (ICD9CM) C0155082) =Disease or Syndrome ;
|
- 107. Kashia Band of Pomo Indians of the Stewarts Point
- (UMLS (HL7) C1554339) =Population Group =NativeEntityContiguous;
| - 157. keratoconjunctivitis
- [simultaneous inflammation of the cornea and conjunctiva. ( CSP )] (UMLS (CSP) C0022573) =Disease or Syndrome ;
=conjunctivitis;
keratitis =KCS;
Keratoconjunctivitis, Infectious;
|
- 108. kat
- [A unit for measuring catalytic (e.g. enzymatic) activity, the ability of the compound to accelerate the chemical reaction by providing a lower energy pathway between the reactants and the products. One katal is that catalytic activity which will raise the rate of reaction by one mole per second in a specified assay system. When the katal is used, the measurand be specified by reference to the measurement procedure; the measurement procedure must identify the indicator reaction. The katal is not used to express a rate of reaction itself, which should be expressed in moles per second. Katal is coherent with the SI. ( NCI )] (UMLS (NCI) C0439245) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 158. KERATOCONJUNCTIVITIS NEC
- [ ] (UMLS (ICD9CM) C0029650) =Disease or Syndrome ;
|
- 109. Kava
- (UMLS (HL7) C1547290) =Intellectual Product =Recreational Drug Use Code;
| - 159. keratoconus
- [noninflammatory, usually bilateral protrusion of the cornea in which the apex is displaced downward and nasally; the conus refers to the cone shape of the corneal protrusion. ( CSP )] (UMLS (CSP) C0022578) =Disease or Syndrome ;
=cornea;
|
- 110. Kaw Nation, Oklahoma
- (UMLS (HL7) C1554340) =Population Group =NativeEntityContiguous;
| - 160. KERATOCONUS, AC HYDROPS
- (UMLS (ICD9CM) C0339286) =Disease or Syndrome ;
|
- 111. Kawaiisu
- (UMLS (HL7) C1551974) =Language =SouthernNumic;
| - 161. KERATOCONUS, STABLE
- [ ] (UMLS (ICD9CM) C0155131) =Disease or Syndrome
|
- 112. Kayser
- [1 cm-1 ( HL7V3.0 )] (UMLS (HL7) C1551082) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 162. Keratoderma
- (UMLS (NCI) C0022579) =Congenital Abnormality ;
|
- 113. KAYSER-FLEISCHER RING
- [ ] (UMLS (ICD9CM) C0152457) =Sign or Symptom
| - 163. keratohyalin
- [ ] (UMLS (CSP) C0064295) =Amino Acid, Peptide, or Protein
|
- 114. KAZ
- [A country in Central Asia, northwest of China. (NCI) ( NCI )] (UMLS (NCI) C0022537) =Geographic Area ;
| - 164. keratomalacia
- [dryness with ulceration and perforation of the cornea, with absence of inflammatory reactions, occurring in cachectic children; results from severe vitamin A deficiency. ( CSP )] (UMLS (CSP) C0152455) =Disease or Syndrome =cornea;
|
- 115. KB cell
- [This line KB is now known to be a subline of the ubiquitous KERATIN-forming tumor cell line HeLa. It was originally thought to be derived from an epidermal carcinoma of the mouth, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via contamination by HELA CELLS. The cells are positive for keratin by immunoperoxidase staining. KB cells have been reported to contain human papillomavirus18 (HPV-18) sequences. ( MSH )] (UMLS (CSP) C0022539) =Cell ;
| - 165. Keratomeleusis
- [ ] (UMLS (ICD9CM) C0339022) =Therapeutic or Preventive Procedure
|
- 116. KCS
- [drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. ( CSP )] (UMLS (CSP) C0022575) =Disease or Syndrome ;
=Dry Eye Syndrome;
keratoconjunctivitis =Sjogren's syndrome | - 166. Keratopathy
- (UMLS (NCI) C0235270) =Disease or Syndrome
|
- 117. KCZ/TAX
- (UMLS (NCI) C0281360) =Therapeutic or Preventive Procedure
| - 167. keratophakia
- [ ] (UMLS (CSP) C0197448) =Therapeutic or Preventive Procedure
|
- 118. KDR
- [This gene plays a role in angiogenesis and vascular regulation. ( NCI )] (UMLS (NCI) C1334306) KDR Gene;
Kinase Insert Domain Receptor (A Type III Receptor Tyrosine Kinase) Gene;
=Gene or Genome | - 168. KERATOPROSTHESIS
- [ ] (UMLS (ICD9CM) C0176217) =Therapeutic or Preventive Procedure
|
- 119. KE
- [A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania. (NCI) ( NCI )] (UMLS (NCI) C0022558) =Geographic Area ;
| - 169. keratosis
- [overgrowth of the upper layer of the skin that is rough, scaly, or gritty in texture, such as a callus or wart. ( CSP )] (UMLS (CSP) C0022593) =Disease or Syndrome ;
=Cutaneous Disorder;
=cholesteatoma;
Darier's disease;
cholesteatoma;
Ichthyosis;
Darier's disease;
Keratoderma, Palmoplantar;
Basal Cell Papilloma;
Parakeratosis;
Porokeratosis;
Callosities;
|
- 120. Kechan
- (UMLS (HL7) C1555636) Quechan;
=Language =River;
| - 170. Keratosis of Larynx
- (UMLS (NCI) C0392050) =Disease or Syndrome ;
|
- 121. Keeshond
- [Keeshonden are compact little animals with a strong resemblance to its ancestor the Samoyed, with oblique chestnut eyes, and erect triangular ears. It has a cream or pale gray undercoat and an outer coat that comes in shades of gray with black tips and stands away from the body. The markings are quite definite and there are distinctive pale "spectacles" around the eyes. Height: 17-19 inches (44-48 cm.) Weight: some sources say 55-66 pounds (25-30kg.) while others say 35-45 pounds (15-20 kg.) ( NCI )] (UMLS (NCI) C0324389) =Mammal
| - 171. Keratotic Basal Cell Carcinoma
- (UMLS (NCI) C1304299) Pilar Basal Cell Carcinoma;
Skin Keratotic Basal Cell Carcinoma;
=Neoplastic Process |
- 122. Keflin
- (UMLS (NCI) C0733789) =Organic Chemical; Antibiotic ;
| - 172. Keratotic Plaque
- [(loo-ko-PLAY-kee-a) A white patch that may develop on mucous membranes such as the cheek, gums, or tongue and may become cancerous. ( NCI )] (UMLS (NCI) C0023531) =Neoplastic Process ;
=Precancerous Condition;
=Leukokeratosis of Oral Mucosa |
- 123. Kefzol
- (UMLS (NCI) C0700925) =Organic Chemical; Antibiotic ;
| - 173. Keratotic Vocal Cord
- (UMLS (NCI) C0264313) =Neoplastic Process
|
- 124. Keisho-To
- [A botanical formulation with potential chemopreventive activities. Sho-Saiko-to, an herbal mixture containing seven herbal extracts, whose mechanism of action if not fully understood, has shown antiproliferative effects against hepatocellular carcinoma in vitro; other effects described in animal models include the prevention of liver injury and hepatocyte-regenerating activity. Antitumor effects associated with this herbal product may include induction of apoptosis, cell cycle arrest at the G0/G1 phase and activation of an immune response, characterized by the release of cytokines as well as activation of effector cells, such as macrophages and natural killer cells. ( NCI )] (UMLS (NCI) C1138004) Minor Bupleurum Formula;
Sho-Saiko-To;
Xiao Chai Hu Tang;
Xiao-Chai-Hu-Tang;
=Pharmacologic Substance ;
| - 174. Keresan
- (UMLS (HL7) C1699745) =Language ;
=AmericanIndianAlaskaNativeLanguages;
=Acoma-Laguna;
Eastern Keres Pueblo |
- 125. Kell system
- [Multiple erythrocytic antigens that comprise at least three pairs of alternates and amorphs, determined by one complex gene or possibly several genes at closely linked loci. The system is important in transfusion reactions. Its expression involves the X-chromosome. ( MSH )] (UMLS (CSP) C0022546) =Body System ;
| - 175. Kerlone
- (UMLS (NCI) C0678122) =Organic Chemical; Pharmacologic Substance ;
|
- 126. keloid
- [progressively enlarging scar resulting from formation of excessive amounts of collagen in the dermis during connective tissue repair; spreads to surrounding tissues. ( CSP )] (UMLS (NCI) C0022548) =Acquired Abnormality ;
=cicatrix;
Collagen Diseases;
Cutaneous Disorder;
=Acne Keloid | - 176. Kernicterus due to isoimmunization of fetus or newborn
- [ ] (UMLS (ICD9CM) C0270204) =Disease or Syndrome
|
- 127. Kemadrin
- (UMLS (NCI) C0022550) =Organic Chemical; Pharmacologic Substance
| - 177. Kernicterus of fetus or newborn not due to isoimmunization
- [ ] (UMLS (ICD9CM) C0158978) =Disease or Syndrome ;
|
- 128. Kemerovo virus
- [A serotype, in the species Great Island virus, of antigenically related tick-borne viruses found in Eastern Europe, Egypt, and Sudan. ( MSH )] (UMLS (CSP) C0022551) =Virus ;
| - 178. kerosene
- [A refined petroleum fraction used as a fuel as well as a solvent. ( MSH )] (UMLS (CSP) C0022611) =Substance ;
|
- 129. Kenaitze Indian Tribe
- (UMLS (HL7) C1550889) =Population Group =NativeEntityAlaska;
| - 179. Kerry Blue Terrier
- [The Kerry Blue Terrier is a well-built, muscular, medium-sized dog with true terrier style and character. It has a long head with abundant whiskers, beard and eyebrows. The ears are v-shaped and crease above the skull to fall toward the outside corner of the eye. The coat is black at birth but changes color through one or more transitions. The mature color is from slate blue to light gray. Height: 171/2-20 inches (44-51 cm.) Weight: 33-40 pounds (15-18 kg.) ( NCI )] (UMLS (NCI) C0324390) =Mammal
|
- 130. Kenalog
- (UMLS (NCI) C0699689) =Steroid; Pharmacologic Substance
| - 180. ketal
- [condensation product of an alcohol plus a carbonyl group in anhydrous acid, having the general form R2-C-(OR)2; acetals have the form R-CH-(OR). ( CSP )] (UMLS (CSP) C0596810) =Organic Chemical ;
=ETHER;
|
- 131. Kenny Caffey syndrome
- [ ] (UMLS (CSP) C0265291) =Congenital Abnormality; Disease or Syndrome
| - 181. Ketalar
- (UMLS (NCI) C0022613) =Organic Chemical; Pharmacologic Substance
|
- 132. Kentucky
- [A state in the north central United States. Its capital is Frankfort. ( NCI )] (UMLS (NCI) C0022557) =Geographic Area ;
| - 182. KETAMINE
- [rapid-acting general anesthetic, animal anesthetic, and emerging drug of abuse. ( CSP )] (UMLS (NCI) C0022614) =Organic Chemical; Pharmacologic Substance =[CN200] ANESTHETICS;
cyclohexane;
cyclohexanone;
[CN203] GENERAL ANESTHETICS, OTHER =Ketamine HCl |
- 133. kepone
- [ ] (UMLS (CSP) C0878176) =Organic Chemical; Hazardous or Poisonous Substance
| - 183. Ketamine HCl
- [The hydrochloride salt form of ketamine, a cyclohexanone derivative with analgesic and anesthetic properties. Although its mechanism of action is not well understood, ketamine appears to block N-methyl-D-aspartate (NMDA) receptors and may interact with sigma receptors, thereby reducing pain perception and inducing sedation. ( NCI )] (UMLS (NCI) C0700541) =Organic Chemical; Pharmacologic Substance =KETAMINE;
=KETAMINE HYDROCHLORIDE 100 MG/ML;
KETAMINE HYDROCHLORIDE 10 MG/ML;
KETAMINE HYDROCHLORIDE 50 MG/ML |
- 134. Keppra
- (UMLS (NCI) C0876060) =Organic Chemical; Pharmacologic Substance
| - 184. Ketchikan Indian Corporation
- (UMLS (HL7) C1550890) =Population Group =NativeEntityAlaska;
|
- 135. keratan sulfate
- [poly(galactose-N-acetylglucosamine sulfate), an important component of the proteoglycan of cartilage and other tissues. ( CSP )] (UMLS (NCI) C0022563) =Carbohydrate; Biologically Active Substance =sulfomucopolysaccharide;
| - 185. Ketek
- (UMLS (NCI) C1452484) =Organic Chemical; Antibiotic
|
- 136. Keratan Sulfate Biosynthesis
- [The chemical reactions and pathways resulting in the formation of keratan sulfate, a glycosaminoglycan with repeat units consisting of beta-1,4-linked D-galactopyranosyl-beta-(1,4)-N-acetyl-D-glucosamine 6-sulfate and with variable amounts of fucose, sialic acid and mannose units; keratan sulfate chains are covalently linked by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylose to peptidyl-threonine or serine residues. [ISBN:0198547684, RESID:AA0247] ( GO )] (UMLS (NCI) C1156904) Keratan Sulfate Biosynthesis Pathway;
=Molecular Function | - 186. ketene
- [general form R2-C=C=O; ketene gas is H2-C=C=O, and is used as an acetylating agent. ( CSP )] (UMLS (CSP) C0124568) =Organic Chemical =KETONE;
acylating agent |
- 137. keratin
- [family of cystine-rich proteins that tend to aggregate in side-to- side fashion, forming tough filaments or sheets; main constituent of intermediate filaments in epidermal tissues. ( CSP )] (UMLS (CSP) C0022564) =Amino Acid, Peptide, or Protein; Biologically Active Substance =cytoskeletal protein;
fibrous protein | - 187. keto fatty acid
- [ ] (UMLS (CSP) C0596811) =Lipid; Biologically Active Substance
|
- 138. Keratin 19 Gene
- [This gene plays a role in cytoskeletal regulation and the corresponding cellular morphology. ( NCI )] (UMLS (NCI) C1334314) KRT19;
KRT19 Gene;
=Gene or Genome ;
| - 188. ketoaldehyde
- [ ] (UMLS (CSP) C0596812) =Organic Chemical ;
|
- 139. Keratin Filament
- [A class of intermediate filaments that form a network within epithelial cells and anchor to desmosomes, thus imparting tensile strength to the tissue ( NCI )] (UMLS (NCI) C1268448) =Cell Component; ;
| - 189. ketogenesis
- [ ] (UMLS (CSP) C0599816) =Molecular Function ;
|
- 140. Keratin Pearls Formation
- (UMLS (NCI) C0334031) =Cell or Molecular Dysfunction
| - 190. ketogenic
- [ ] (UMLS (CSP) C0599817) =Molecular Function ;
|
- 141. KERATIN RIDGE MUCOSA-MIN
- [ ] (UMLS (ICD9CM) C1456227) Minimal keratinized residual ridge mucosa;
=Disease or Syndrome ;
| - 191. ketoglutarate dehydrogenase
- [ ] (UMLS (CSP) C0599061) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 142. Keratinizing Epidermoid Carcinoma in situ of Nasopharynx
- (UMLS (NCI) C0862753) Keratinizing Epidermoid Carcinoma in situ of the Nasopharynx;
Keratinizing Squamous Cell Carcinoma in situ of Nasopharynx;
Keratinizing Squamous Cell Carcinoma in situ of the Nasopharynx;
Nasopharyngeal Keratinizing Epidermoid Carcinoma in situ;
Nasopharyngeal Keratinizing Squamous Cell Carcinoma in situ;
Nasopharynx Keratinizing Epidermoid Carcinoma in situ;
Nasopharynx Keratinizing Squamous Cell Carcinoma in situ;
Stage 0 Keratinizing Epidermoid Carcinoma of Nasopharynx;
Stage 0 Keratinizing Epidermoid Carcinoma of the Nasopharynx;
Stage 0 Keratinizing Squamous Cell Carcinoma of Nasopharynx;
Stage 0 Keratinizing Squamous Cell Carcinoma of the Nasopharynx;
Stage 0 Nasopharyngeal Keratinizing Epidermoid Carcinoma;
Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma;
Stage 0 Nasopharynx Keratinizing Epidermoid Carcinoma;
Stage 0 Nasopharynx Keratinizing Squamous Cell Carcinoma =Neoplastic Process | - 192. ketone oxidoreductase
- [Oxidoreductases that are specific for KETONES. ( MSH )] (UMLS (CSP) C0022632) =Amino Acid, Peptide, or Protein; Enzyme
|
- 143. Keratinizing Epidermoid Carcinoma of Nasopharynx
- [A nasopharyngeal carcinoma showing squamous differentiation in the form of intercellular bridges or keratinization over most of its extend (Sternberg's Diagnostic Surgical Pathology, 3rd ed., 1999). —2002 ( NCI )] (UMLS (NCI) C0279698) =Neoplastic Process
| - 193. KETOROLAC TROMETHAMINE
- [The tromethamine salt of ketorolac, a synthetic pyrrolizine carboxylic acid derivative with anti-inflammatory, analgesic and antipyretic properties. Ketorolac tromethamine, a non-selective inhibitor of the cyclooxygenases (COX), inhibits both COX-1 and COX-2 enzymes. This agent exerts its anti-inflammatory effect by preventing conversion of arachidonic acid to prostaglandins at inflammation site mediated through inhibition of COX-2, undetectable in most tissues but is up-regulated at the inflammation sites by cytokines stimulation. Since COX-1 is expressed virtually in all tissues, inhibition of COX-1 enzyme by this agent prevents normal state production of prostaglandins, which plays housekeeping roles in the protection of the gastrointestinal tract, regulating renal blood flow, and functioning in platelet aggregation. As a result, inhibition of COX-1 is usually associated with adverse effects such as gastrointestinal toxicity and nephrotoxicity. ( NCI )] (UMLS (NCI) C0064326) =Organic Chemical; Pharmacologic Substance ;
=1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-H-indole-3-acetic acid;
KETOROLAC =KETOROLAC TROMETHAMINE 0.5 %;
KETOROLAC TROMETHAMINE 10 MG;
KETOROLAC TROMETHAMINE 15 MG/ML;
KETOROLAC TROMETHAMINE 30 MG/ML;
|
- 144. Keratinizing Primary Intraosseous Squamous Cell Carcinoma Arising de novo
- (UMLS (NCI) C1334322) Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type =Neoplastic Process ;
| - 194. ketosteroid
- [Steroid derivatives formed by oxidation of a methyl group on the side chain or a methylene group in the ring skeleton to form a ketone. ( MSH )] (UMLS (CSP) C0022640) =Steroid ;
=Steroid;
=17-Ketosteroids |
- 145. Keratinizing Squamous Cell Carcinoma
- [Squamous cell carcinomas with morphologically prominent production of keratin. ( NCI )] (UMLS (NCI) C0334247) =Neoplastic Process
| - 195. ketotic glycinemia
- [elevated accumulation and excretion of glycine accompanied by ketosis that is secondary to methylmalonicacidemia, isovalericacidemia and other organic acidemias, as distinguished from nonketotic hyperglycinemia. ( CSP )] (UMLS (CSP) C0268579) =Disease or Syndrome =enzyme deficiency;
hyperglycinemia |
- 146. Keratinocyte
- [vertebrate, epidermal cell of ectodermal origin. ( CSP )] (UMLS (NCI) C0022567) =Cell ;
= ;
Integument | - 196. KETOTIFEN
- [A cycloheptathiophene derivative with anti-allergic activity. Ketotifen selective blocks histamine (H1) receptors and prevents the typical symptoms caused by histamine release. This agent also interferes with the release of inflammatory mediators from mast cells involved in hypersensitivity reactions, thereby decreasing chemotaxis and activation of eosinophils. ( NCI )] (UMLS (NCI) C0022642) =Organic Chemical; Pharmacologic Substance =Piperidines;
Thiophenes;
[OP900] OPHTHALMICS, OTHER;
=10H-Benzo(4,5)cyclohepta(1,2-b)thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-,(E)-2-butenedioate(1:1) |
- 147. Keratinocyte Differentiation
- [Differentiation of keratinocytes to the fully differentiated keratinocyte phenotype. ( NCI )] (UMLS (NCI) C1159909) =Cell Function
| - 197. Ketrax
- (UMLS (NCI) C0733387) =Organic Chemical; Pharmacologic Substance
|
- 148. keratinocyte growth factor
- [A fibroblast growth factor that is a specific mitogen for EPITHELIAL CELLS. It binds a complex of HEPARAN SULFATE and FIBROBLAST GROWTH FACTOR RECEPTOR 2B. ( MSH )] (UMLS (CSP) C0064294) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 198. Kevadon
- (UMLS (NCI) C0729006) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
|
- 149. Keratinocyte Growth Factor Therapy
- (UMLS (NCI) C0677833) =Therapeutic or Preventive Procedure ;
| - 199. Keweenaw Bay Indian Community of L'Anse and Ontona
- (UMLS (HL7) C1554341) =Population Group =NativeEntityContiguous;
|
- 150. Keratinous Cyst of Scrotum
- (UMLS (NCI) C0341789) =Finding
| - 200. Key
- [Key - this message element is used as a key to set or collection of message elements ( HL7V3.0 )] (UMLS (HL7) C1554080) =Idea or Concept =HL7UpdateMode;
|
home
